Abstract
The acute toxicological effects of the nephrotoxic antibiotic cephaloridine (CPH, 0–1500 mg/kg) in male Fischer 344 (F344) rats, have been investigated over 48 h using clinical chemistry, histopathology and proton nuclear magnetic resonance (1H NMR) spectroscopy of urine and plasma. High field (400 and 600 MHz)1H NMR urinalysis revealed increased excretion of lactic acid, acetoacetate, alanine, valine, lysine, glutamine and glutamate and a severe, time-dependent glycosuria. A major change observed in urine of CPH-treated animals was the dose-dependent increase in HB which may relate to altered energy metabolism. CPH also caused dose-dependent decreases in the urinary excretion of hippurate, allantoin and protein (conventional assay). This abnormal metabolic profile is consistent with a functional defect in the S1/S2 regions of the proximal tubule, and was confirmed by histologypost mortem. Functional changes observed included elevations in blood urea nitrogen (BUN) and urine flow rate (UFR) and dose-related decreases in urine osmolality. Spin-echo1H NMR spectroscopic analysis of lyophilised plasma, reconstituted with2H2O revealed an abnormal phase modulation of the methyl signal from free alanine and it is postulated that this is due to the release of transaminases from damaged tissue which via a reversible conversion to pyruvate, cause variable deuteration of alanine at the α-CH position. This observation suggests that1H NMR spectral patterns are also dependent on the level of plasma transaminases and this may provide a novel indicator of tissue damage.
Similar content being viewed by others
Abbreviations
- ALT:
-
Alanine aminotransferase
- BUN:
-
blood urea nitrogen
- CPH:
-
cephaloridine
- DMA:
-
dimethylamine
- DMG:
-
N,N-dimethyl-glycine
- EDTA:
-
ethylenediaminetetraacetic acid
- FID:
-
free induction decay
- F344:
-
Fischer 344
- α-glucose:
-
α-anomeric proton of glucose
- GSH:
-
glutathione
- HB:
-
3-d-hydroxybutyric acid
- HSE:
-
Hahn spin-echo
- IMP:
-
imipenem
- i.p.:
-
intraperitoneal
- i.v.:
-
intravenous
- MW:
-
molecular weight
- HgCl2 :
-
mercuric chloride
- 1H NMR:
-
proton nuclear magnetic resonance
- PAP:
-
4-aminophenol
- SD:
-
Sprague-Dawley
- TMAO:
-
trimethylamine N-oxide
- TSP:
-
3-trimethylsilyl-[2,2,3,3-2H4]-1-propionate
- UFR:
-
urine flow rate
- UN:
-
uranyl nitrate
References
Atkinson RM, Caisey JD, Currie JP, Middleton TR, Pratt DAH, Sharpe HM, Tomich EG (1966) Subacute toxicity of cephaloridine to various species. Toxicol Appl Pharmacol 8: 407–428
Babu UM, Johnston RB (1976) Nuclear magnetic resonance studies of D20-substrate exchange reactions catalysed by glutamic pyruvic and glutamic oxaloacetic transaminases. Biochemistry 15 [25]: 5671–5678
Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ (1984) Use of high resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem 30: 426–432
Bales JR, Bell JD, Nicholson JK, Sadler PJ (1986)1H NMR studies of urine during fasting: excretion of ketone bodies and acetylcarnitine. Mag Reson Med 3: 849–856
Barac-Nieto M (1985) Renal hydroxybutyrate and acetoacetate reabsorption and utilisation in the rat. Am J Physiol 249: F257-F265
Child KJ, Dodds MG (1966) Mechanism of urinary excretion of cephaloridine and its effects on renal function in animals. Br J Pharmacol 26: 108–119
Cojocel C, Smith JH, Maita K, Sleight SD, Hook JB (1983) Renal protein degradation: a biochemical target of specific nephrotoxicants. Fundam Appl Tox 3: 278–284
Cojocel C, Hannemann J, Baumann K (1985) Cephaloridine-induced lipid peroxidation initiated by reactive oxygen species as a possible mechanism of cephaloridine nephrotoxicity. Biochem Biophys Acta 834: 402–410
Foord RD (1975) Cephaloridine, cephalothin and the kidney. J Antimicrob Chemother 1: 119
Foxall PJD, Mellotte GJ, Bending MR, Lindon JC, Nicholson JK (1992) High resolution proton nuclear magnetic resonance spectroscopy of urine as a novel approach to the monitoring of renal transplant function. Kidney Int (in press)
Gartland KPR, Bonner FW, Nicholson JK (1989 a) Investigations into the biochemical effects of region-specific nephrotoxins. Mol Pharmacol 35: 242–250
Gartland KPR, Bonner FW, Timbrell JA, Nicholson JK (1989 b) Biochemical characterisation of para-aminophenol-induced nephrotoxic lesions in the F344 rat. Arch Toxicol 63: 97–106
Gartland KPR, Anthony ML, Beddell CR, Lindon JC, Nicholson JK (1990) PMR studies on the effects of uranyl nitrate on the biochemical composition of rat urine and plasma. J Pharm Biomed Anal 8 [8–12]: 951–954
Goldstein RS, Pasino DA, Hook JB (1986) Cephaloridine nephrotoxicity in aging male Fischer-344 rats. Toxicology 38: 43–53
Goldstein RS, Contardi LR, Pasino DA, Hook JB (1987) Mechanisms mediating cephaloridine inhibition of renal gluconeogenesis. Toxicol Appl Pharmacol 87: 297–305
Hahn EL (1950) Spin echoes. Physics Rev 80: 580–594
Harrison MP, Jones DV, Pickford RJ, Wilson ID (1991) β-Hydroxybutyrate: a urinary marker of imipenem induced nephrotoxicity in the cynomolgus monkey detected by high field1H NMR spectroscopy. Biochem Pharmacol 41 [12]: 2045–2049
Holmes E, Foxall PJD, Nicholson JK (1990) Proton NMR analysis of plasma from renal failure patients: evaluation of sample preparation and spectral-editing methods. J Pharm Biomed Anal 8: 955–958
Hoppel CL, Genuth SM (1982) Urinary excretion of acetylcarnitine during human diabetic and fasting ketosis. Am J Physiol 243: E168-E172
Kida K, Nakajo S, Kamija F, Nishio T, Nakagawa H (1978) Renal net glucose release in vivo and its contribution to blood glucose in rats. J Clin Invest 62: 721–726
Kuo CH, Hook JB (1982) Depletion of renal glutathione content and nephrotoxicity of cephaloridine in rabbits, rats and mice. Toxicol Appl Pharmacol 63: 292–302
Kuo CH, Maita K, Sleight SD, Hook JB (1983) Lipid peroxidation: a possible mechanism of cephaloridine-induced nephrotoxicity. Toxicol Appl Pharmacol 67: 78–88
Lowry OH, Rosebrough NJ, Farr AL, Dandall RJ (1951) Protein measurement with the Folin-phenol reagent. J Biol Chem 193: 265–275
McMurtry RJ, Mitchell JR (1977) Renal and hepatic necrosis after metabolic activation of 2-substituted furans and thiophenes, including furosemide and cephaloridine. Toxicol Appl Pharmacol 42: 285–300
Miyajima H, Hewitt WR, Cote MG, Plaa GL (1983) Relationships between histological and functional indices of acute chemically induced nephrotoxicity. Fundam Appl Toxicol 3: 543–551
Murgatroyd LB, Pickford R, Smith IK, Wilson ID (1992)1H NMR spectroscopy as a means of monitoring nephrotoxicity as exemplified by studies with cephaloridine. Hum Exp Toxicol 11: 35–41
Nicholson JK, Gartland KPR (1987) A nuclear magnetic resonance approach to investigate the biochemical and molecular effects of nephrotoxins. In: Reid E, Cook GMW, Luzio JP (eds) Cells, membranes and disease, including renal. Methodological surveys in biochemistry and analysis. Vol 17. Plenum Press, New York, pp 397–408
Nicholson JK, Wilson ID (1989) High resolution proton magnetic resonance spectroscopy of biological fluids. Progress in NMR Spectroscopy 21: 449–501
Nicholson JK, O'Flynn MP, Sadler PJ, Macleod AF, Juul SM, Sonksen PH (1984) Proton nuclear magnetic resonance studies of serum, plasma and urine from fasting, normal and diabetic subjects. Biochem J 217: 365–375
Nicholson JK, Timbrell JA, Sadler PJ (1985) Proton NMR spectra of urine as indicators of renal damage: Mercury-induced nephrotoxicity in rats. Mol Pharmacol 27: 644–651
Owen O, Licht JH, Sapir DG (1981) Renal function and effects of partial rehydration during diabetic ketoacidosis. Diabetes 30: 510–518
Pickford R, Smith IK, Wilson ID (1988) A note on urinalysis by1H NMR, application to cephaloridine treated rats. In: Reid E, Robinson JD, Wilson ID (eds) Bioanalysis of drugs and metabolites. Plenum Publishing Corporation, New York, pp 371–374
Raab W, Moerth C (1976) Renal effects of gentamycin and cephaloridine-evaluation by renal enzyme excretion studies in rats and comparison with other antibiotics. Arzneimittelforschung 26: 377–379
Sapir DG, Owen O (1975) Renal conservation of ketone bodies during starvation. Metabolism 24: 23–33
Stewart GT, Holt RJ (1964) Laboratory and clinical results with cephaloridine. Lancet 1305–1309
Tune BM (1972) Effect of organic acid transport inhibitors on renal cortical uptake and proximal tubular toxicity of cephaloridine. J Pharmacol Exp Ther 181: 250–256
Tune BM (1975) Relationship between the transport and toxicity of cephalosporins in the kidney. J Infect Dis 132: 189–194
Tune BM, Fernholt M (1973) Relationship between cephaloridine andp-aminohippurate transport in the kidney. Am J Physiol 225: 1114–1117
Tune BM, Wu KY, Longerbeam DF, Kempson RL (1977) Transport and toxicity of cephaloridine in the kidney. Effect of furosemide,p-aminohippurate and saline diuresis. J Pharmacol Exp Ther 202: 472–478
Tune BM, Wu KY, Fravert D, Holtzmann D (1979) Effect of cephaloridine on respiration by renal mitochondria. J Pharmacol Exp Ther 210: 98–100
Tune BM, Sibley RK, Hsu CY (1987) The mitochondrial respiratory toxicity of cephalosporin antibiotics. An inhibitory effect on substrate uptake. J Pharmacol Exp Ther 245: 1054–1059
Tune BM, Fravert D, Hsu CY (1989) The oxidative and mitochondrial toxic effects of cephalosporin antibiotics in the kidney. A comparative study of cephaloridine and cephaloglycin. Biochem Pharmacol 38: 795–802
Valentovic MA, Ball JG, Elliott C, Madan E (1989) Cephaloridine nephrotoxicity in streptozotocin induced diabetic F344 rats. Toxicology 57: 193–207
Wilson NM, Brown PM, Juul SM, Prestwich SA, Sonksen PH (1981) Glucose turnover and metabolic and hormonal changes in ethanol-induced hypoglycaemia. BMJ 282: 849–853
Wirthensohn G, Guder WG (1983) Renal lipid metabolism. Mineral Elect Metab 9: 203–211
Wold JS, Turnipseed SA (1977) Determination of cephaloridine in serum and tissue by high-performance liquid chromatography. J Chromatograph 136: 170
Wold JS, Turnipseed SA (1980) The effect of renal cation transport inhibitors on the in vivo and in vitro accumulation and efflux of cephaloridine. Life Sci 27: 2559–2564
Wold JS, Joost RR, Owen NV (1977) Nephrotoxicity of cephaloridine in newborn rabbits: role of the renal anionic transport system. J Pharmacol Exp Ther 201: 778–785
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Anthony, M.L., Gartland, K.P.R., Beddell, C.R. et al. Cephaloridine-induced nephrotoxicity in the Fischer 344 rat: proton NMR spectroscopic studies of urine and plasma in relation to conventional clinical chemical and histopathological assessments of nephronal damage. Arch Toxicol 66, 525–537 (1992). https://doi.org/10.1007/BF01973382
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01973382